| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Watts Ryan J.77 | President And CEO | Sell | 4,800 | $28.44 | $136,512.00 | -0.2% | -16.1% | -32.7% | |
| Jan 5, 2023 | Schuth Alexander O.75 | Cofo And Secretary | Sell | 2,636 | $28.44 | $74,967.84 | -0.5% | -16.1% | -32.7% | |
| Jan 4, 2023 | Schuth Alexander O.75 | Cofo And Secretary | Sell | 2,912 | $28.70 | $83,574.40 | -1.9% | -18.1% | -29.9% | |
| Jan 4, 2023 | Watts Ryan J.77 | President And CEO | Sell | 5,029 | $28.73 | $144,483.17 | -0.2% | -18.1% | -29.9% | |
| Jan 4, 2023 | Ho Carole73 | Chief Medical Officer | Sell | 2,913 | $28.69 | $83,573.97 | -1.6% | -18.1% | -29.9% | |
| Nov 23, 2022 | Tessier-Lavigne Marc69 | Director | Sell | 20,000 | $30.48 | $609,600.00 | -1.1% | -5.5% | -39.5% | |
| Nov 2, 2022 | Tessier-Lavigne Marc69 | Director | Sell | 20,000 | $30.27 | $605,462.76 | -0.5% | -1.5% | -36.3% | |
| Sep 28, 2022 | Tessier-Lavigne Marc69 | Director | Sell | 20,000 | $30.82 | $616,303.82 | -0.5% | -16.9% | -34.7% | |
| Aug 23, 2022 | Ho Carole73 | Chief Medical Officer | Sell | 2,424 | $31.98 | $77,519.52 | -1.4% | -8.3% | -28.9% | |
| Aug 23, 2022 | Tessier-Lavigne Marc69 | Director | Sell | 20,000 | $31.61 | $632,282.00 | -0.5% | -8.3% | -28.9% |